JPWO2020081839A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020081839A5
JPWO2020081839A5 JP2021515005A JP2021515005A JPWO2020081839A5 JP WO2020081839 A5 JPWO2020081839 A5 JP WO2020081839A5 JP 2021515005 A JP2021515005 A JP 2021515005A JP 2021515005 A JP2021515005 A JP 2021515005A JP WO2020081839 A5 JPWO2020081839 A5 JP WO2020081839A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
pharmaceutically acceptable
administered
patient
formulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021515005A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022503733A (ja
JP2022503733A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/056772 external-priority patent/WO2020081839A1/en
Publication of JP2022503733A publication Critical patent/JP2022503733A/ja
Publication of JPWO2020081839A5 publication Critical patent/JPWO2020081839A5/ja
Publication of JP2022503733A5 publication Critical patent/JP2022503733A5/ja
Pending legal-status Critical Current

Links

JP2021515005A 2018-10-17 2019-10-17 口腔粘膜炎を治療するための方法および組成物 Pending JP2022503733A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862746943P 2018-10-17 2018-10-17
US62/746,943 2018-10-17
PCT/US2019/056772 WO2020081839A1 (en) 2018-10-17 2019-10-17 Methods and compositions for treating oral mucositis

Publications (3)

Publication Number Publication Date
JP2022503733A JP2022503733A (ja) 2022-01-12
JPWO2020081839A5 true JPWO2020081839A5 (https=) 2022-10-26
JP2022503733A5 JP2022503733A5 (https=) 2022-10-26

Family

ID=70281364

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021515005A Pending JP2022503733A (ja) 2018-10-17 2019-10-17 口腔粘膜炎を治療するための方法および組成物

Country Status (12)

Country Link
US (2) US11123357B2 (https=)
EP (1) EP3866810A4 (https=)
JP (1) JP2022503733A (https=)
KR (1) KR20210075968A (https=)
CN (1) CN112839662A (https=)
AU (1) AU2019361999A1 (https=)
BR (1) BR112021006954A2 (https=)
CA (1) CA3116157A1 (https=)
IL (1) IL282100A (https=)
MX (1) MX2021004396A (https=)
SG (1) SG11202103180QA (https=)
WO (1) WO2020081839A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12030908B2 (en) 2017-03-10 2024-07-09 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
US11795192B2 (en) * 2017-03-10 2023-10-24 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
WO2024129985A2 (en) * 2022-12-14 2024-06-20 Lakewood Amedex, Inc. Antiviral compounds, compositions, and uses thereof
WO2025179296A1 (en) * 2024-02-22 2025-08-28 Lakewood Amedex, Inc. Crystalline forms of nu-3 and uses thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US5167950A (en) 1991-03-28 1992-12-01 S. C. Johnson & Son High alcohol content aerosol antimicrobial mousse
WO1995024179A1 (en) 1994-03-11 1995-09-14 The Procter & Gamble Company LOW pH, HYDROLYTICALLY STABLE, COSMETIC COMPOSITIONS CONTAINING ACIDIC ACTIVES
US7868162B2 (en) * 1998-12-30 2011-01-11 Lakewood-Amedex, Inc. Antimicrobial and antiviral compounds and methods for their use
US6211349B1 (en) 1998-12-30 2001-04-03 Oligos Etc., Inc. Protonated/acidified nucleic acids and methods of use
US20020032164A1 (en) 1998-12-30 2002-03-14 Dale Roderic M. K. Antimicrobial compounds and methods for their use
US6211162B1 (en) 1998-12-30 2001-04-03 Oligos Etc. Inc. Pulmonary delivery of protonated/acidified nucleic acids
CZ296576B6 (cs) 1999-02-12 2006-04-12 Sankyo Company Limited Nukleosidový analog a oligonukleotidový analog a farmaceutický prostredek, sonda a primer s jeho obsahem
US6946118B1 (en) * 1999-09-14 2005-09-20 Orapharma, Inc. Formulations for treating or preventing mucositis
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
WO2003032909A2 (en) 2001-10-18 2003-04-24 Ilex Products, Inc. Methods of treating skin with diphosphonate derivatives
AU2003230952A1 (en) * 2002-05-21 2003-12-12 Abbott Laboratories Treatment of mucositis
CN1687100A (zh) * 2005-04-05 2005-10-26 奥林格斯技术有限公司 修饰性核苷酸及其用途
US8227431B2 (en) 2008-03-17 2012-07-24 Hetero Drugs Limited Nucleoside derivatives
US8884000B2 (en) 2010-02-17 2014-11-11 Albert Einstein College Of Medicine Of Yeshiva University Saporin-L1 inhibitors and uses thereof
EP2601205A2 (en) * 2010-08-03 2013-06-12 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Guanine nucleotide derivatives for treating bacterial infections
AU2013264820A1 (en) * 2012-05-23 2014-11-27 Cellixbio Private Limited Compositions and methods for treatment of mucositis
WO2014124430A1 (en) 2013-02-11 2014-08-14 Emory University Nucleotide and nucleoside therapeutic compositions and uses related thereto
WO2015075406A1 (en) 2013-11-19 2015-05-28 Lipopeptide Ab New treatment of chronic ulcers
EP3215126A1 (en) 2014-10-30 2017-09-13 Biomet Manufacturing, LLC Methods of preventing surgical site infections
US10172786B2 (en) 2014-12-16 2019-01-08 Axim Biotechnologies, Inc. Oral care composition comprising cannabinoids
US20200306119A1 (en) * 2016-03-23 2020-10-01 University Of Utah Research Foundation Spinal traction device
JP6917078B2 (ja) * 2017-03-10 2021-08-11 レイクウッド アメディックス、インコーポレイテッド 抗菌化合物、組成物、及びそれらの使用
FI3638251T3 (fi) * 2017-06-12 2024-04-29 Lakewood Amedex Inc Bisfosfosiinin geeliformulaatioita ja niiden käyttötapoja

Similar Documents

Publication Publication Date Title
JP2668800B2 (ja) 皮膚疾患の局所治療
JP3597333B2 (ja) 急性鼻炎を処置するための医薬製剤
KR20010107662A (ko) 미노시클린 함유 조성물
JP2019189650A5 (https=)
JPH032126A (ja) 口腔内抗真菌予防薬およびその使用法
JPH0597668A (ja) 歯周炎の治療
RU2005133665A (ru) Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств
JPWO2020081839A5 (https=)
US20080268022A1 (en) Mehtods for treating and preventing ailments caused by human papillomavirus
RU2420257C1 (ru) Стоматологический гель с хлоргексидином и дибунолом для лечения воспалительных заболеваний пародонта и слизистой оболочки полости рта
JPH0489428A (ja) 多形核白血球活性化剤
RU2005105302A (ru) Композиция бицифадина
EP1207861B1 (en) Treatment of fungal infections utilizing a fungal growth medium
GB2167296A (en) Topical pharmaceutical compositions containing glycyrrhizin
US20110160166A1 (en) Therapeutic composition for the treatment and prevention of athlete's foot and fungal infections of the nail and surrounding tissues
JPS5877824A (ja) インターフェロンを含む組成物
AU754329B2 (en) Fungicide composition comprising a benzoylphenylurea
EP0086228A1 (en) USE OF CARBAMIDE PEROXIDE FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING ACNE VULGARIS.
US2988480A (en) Therapeutically active compositions
US7655668B1 (en) Composition and method for treatment of warts
RU2238092C2 (ru) Водная лекарственная композиция для лечения заболеваний кожи
RU2467738C1 (ru) Стоматологическая мазь с хлоргексидином и аминокапроновой кислотой для комплексного лечения воспалительных заболеваний пародонта
US11951082B2 (en) Composition of chlorhexidine
JPH10175852A5 (https=)
JPH11286448A (ja) ミノサイクリン含有組成物